CB4211 was well-tolerated and appeared safe with no serious adverse events
Robust reductions in ALT and AST
Reduction in glucose and trend towards body weight reduction
Company to host conference call and webcast
Conference Call:
Date: August 10, 2021
Time: 5:00 p.m. ET (2:00 p.m. PT)
Conference Audio
Dial-in U.S. and Canada: (877) 300-8521
Dial-in International: (412) 317-6026
Conference ID No.: 10159293
Slide Presentation
Please visit https://us02web.zoom.us/j/84796437737?pwd=R2t0eEFRVDVlVDVZMTdhT0pGWVVsUT09 and enter password CWBR, or
Go to www.cohbar.com and click on CohBar Q2 2021 Investor Presentation at the top of homepage.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.